ArticlePhysical and engineering sciences in medicine2026
Hybrid imaging-clinical model for predicting microvascular invasion in hepatocellular carcinoma using deep learning-derived features from CT.
Article in Physical and engineering sciences in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The role of adipose tissue in predicting microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC) remains unclear. This study proposes a method that integrates deep learning and machine learning techniques to investigate the role of adipose tissue in identifying MVI status in HCC patients. We collected enhanced Computed Tomography images from 517 HCC patients across two independent centers, dividing them into a training set, validation set, and test set. The model was constructed using adipose and tumor deep learning features along with clinical features, and the features were input into a classifier for prediction. The model performance was evaluated using the area under the curve(AUC), decision curve analysis, scatter plots, and box plots. Furthermore, we compared the model's performance with that of three radiologists. After incorporating the adipose tissue modality, the venous-phase AUC reached 0.866 (95% CI 0.803-0.920), while the arterial-phase AUC was 0.864 (95% CI 0.792-0.920). The inclusion of the adipose tissue modality provided significant value for clinical diagnosis, which was further validated through visualization analysis. Using predicted labels for grouping, it shows that the overall survival of the high-risk group was significantly lower than that of the low-risk group. Comparative analysis showed that the predictive performance of the model surpassed that of radiologists. Univariate analysis identified the adipose region as a risk factor for predicting MVI status. We developed a hybrid multimodal model that performed comparably to radiologists' assessments. The inclusion of the adipose tissue modality enhanced the accuracy of MVI diagnosis.
Indexed as
Identifiers
41553627What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.